🇺🇸 FDA
Pipeline program

ASC30 tablets

ASC30-203

Phase 2 small_molecule active

Quick answer

ASC30 tablets for T2DM (Type 2 Diabetes Mellitus) is a Phase 2 program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
T2DM (Type 2 Diabetes Mellitus)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials